Value of Information and Pricing New Healthcare Interventions Andrew R. WillanSimon Eckermann Leading Article 23 December 2012 Pages: 447 - 459
A Critical Review of Model-Based Economic Studies of Depression Hossein Haji Ali AfzaliJonathan KarnonJodi Gray Review Article 23 December 2012 Pages: 461 - 482
Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura Dwayne BoyersXueli JiaGraham Mowatt Review Article 23 December 2012 Pages: 483 - 495
Pharmacoeconomics of the Myeloid Growth Factors Bradford R. HirschGary H. Lyman Systematic Review 23 December 2012 Pages: 497 - 511
Cost Effectiveness of Quetiapine in Patients with Acute Bipolar Depression and in Maintenance Treatment after an Acute Depressive Episode Mattias EkmanPeter LindgrenMary Lou Chatterton Original Research Article 23 December 2012 Pages: 513 - 530
The Lack of Impact of Quality-of-Life Measures in Schizophrenia: A Shared Responsibility? Laurent BoyerPascal Auquier Correspondence 23 December 2012 Pages: 531 - 532
The Authors’ Reply A. George AwadLakshmi N. P. Voruganti Correspondence 23 December 2012 Pages: 532 - 533
Erratum to Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX study Laura T. PizziAmy TalatiPeter K. Sand Erratum 23 December 2012 Pages: 534 - 535